OBJECTIVE : To evaluate the relationship between use of fertility medication ( i.e. , selective estrogen receptor [ ER ] modulator , gonadotropin , or other ) or infertility treatment ( i.e. , IVF or IUI ) and the risk of ovarian cancer among women with a BRCA1 or BRCA2 mutation .